A detailed history of Hardman Johnston Global Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Hardman Johnston Global Advisors LLC holds 126,644 shares of JNJ stock, worth $19.7 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
126,644
Previous 139,084 8.94%
Holding current value
$19.7 Million
Previous $20.3 Million 0.96%
% of portfolio
0.84%
Previous 0.82%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$145.48 - $167.38 $1.81 Million - $2.08 Million
-12,440 Reduced 8.94%
126,644 $20.5 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $674,254 - $736,832
-4,670 Reduced 3.25%
139,084 $20.3 Million
Q1 2024

May 06, 2024

BUY
$155.22 - $162.74 $24,369 - $25,550
157 Added 0.11%
143,754 $22.7 Million
Q4 2023

Jan 29, 2024

SELL
$145.6 - $158.88 $102,211 - $111,533
-702 Reduced 0.49%
143,597 $22.5 Million
Q3 2023

Oct 20, 2023

SELL
$155.75 - $174.48 $175,997 - $197,162
-1,130 Reduced 0.78%
144,299 $22.5 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $616,319 - $663,277
-3,993 Reduced 2.67%
145,429 $24.1 Million
Q1 2023

May 05, 2023

SELL
$151.05 - $180.26 $715,977 - $854,432
-4,740 Reduced 3.07%
149,422 $23.2 Million
Q4 2022

Feb 03, 2023

SELL
$160.2 - $179.79 $385,281 - $432,394
-2,405 Reduced 1.54%
154,162 $27.2 Million
Q3 2022

Nov 02, 2022

BUY
$161.33 - $179.52 $215,375 - $239,659
1,335 Added 0.86%
156,567 $25.6 Million
Q2 2022

Aug 02, 2022

SELL
$168.19 - $186.01 $204,350 - $226,002
-1,215 Reduced 0.78%
155,232 $27.6 Million
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $201,628 - $228,977
-1,275 Reduced 0.81%
156,447 $27.7 Million
Q4 2021

Jan 26, 2022

SELL
$155.93 - $173.01 $562,595 - $624,220
-3,608 Reduced 2.24%
157,722 $27 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $84,949 - $94,401
-526 Reduced 0.32%
161,330 $26.1 Million
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $106,532 - $114,274
-668 Reduced 0.41%
161,856 $26.7 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $204,348 - $227,590
-1,335 Reduced 0.81%
162,524 $26.7 Million
Q4 2020

Feb 11, 2021

SELL
$137.11 - $157.38 $56,215 - $64,525
-410 Reduced 0.25%
163,859 $25.8 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $77,910 - $85,375
-555 Reduced 0.34%
164,269 $24.5 Million
Q2 2020

Jul 23, 2020

SELL
$128.81 - $155.51 $28,338 - $34,212
-220 Reduced 0.13%
164,824 $23.2 Million
Q1 2020

May 04, 2020

SELL
$111.14 - $153.99 $450,117 - $623,659
-4,050 Reduced 2.4%
165,044 $21.6 Million
Q4 2019

Feb 05, 2020

SELL
$127.5 - $146.44 $267,112 - $306,791
-2,095 Reduced 1.22%
169,094 $24.7 Million
Q3 2019

Oct 30, 2019

SELL
$126.95 - $142.14 $2,539 - $2,842
-20 Reduced 0.01%
171,189 $22.1 Million
Q2 2019

Aug 05, 2019

SELL
$131.15 - $144.24 $546,895 - $601,480
-4,170 Reduced 2.38%
171,209 $23.8 Million
Q1 2019

May 03, 2019

SELL
$125.72 - $139.79 $707,175 - $786,318
-5,625 Reduced 3.11%
175,379 $24.5 Million
Q4 2018

Feb 06, 2019

SELL
$122.84 - $147.84 $115,469 - $138,969
-940 Reduced 0.52%
181,004 $23.4 Million
Q3 2018

Oct 18, 2018

SELL
$121.58 - $142.88 $111,853 - $131,449
-920 Reduced 0.5%
181,944 $25.1 Million
Q2 2018

Jul 18, 2018

SELL
$119.4 - $131.76 $1.15 Million - $1.27 Million
-9,625 Reduced 5.0%
182,864 $22.2 Million
Q1 2018

Apr 30, 2018

SELL
$125.1 - $148.14 $360,913 - $427,383
-2,885 Reduced 1.48%
192,489 $24.7 Million
Q4 2017

Jan 26, 2018

SELL
$131.22 - $143.62 $92,903 - $101,682
-708 Reduced 0.36%
195,374 $27.3 Million
Q3 2017

Oct 30, 2017

BUY
$129.47 - $135.38 $240,814 - $251,806
1,860 Added 0.96%
196,082 $25.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
194,222
194,222 $25.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Hardman Johnston Global Advisors LLC Portfolio

Follow Hardman Johnston Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardman Johnston Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardman Johnston Global Advisors LLC with notifications on news.